BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31144472)

  • 1. Whole exome sequencing identifies a new mutation in the SLC19A2 gene leading to thiamine-responsive megaloblastic anemia in an Egyptian family.
    Amr K; Pawlikowska P; Aoufouchi S; Rosselli F; El-Kamah G
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00777. PubMed ID: 31144472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First 2 cases with thiamine-responsive megaloblastic anemia in the Czech Republic, a rare form of monogenic diabetes mellitus: a novel mutation in the thiamine transporter SLC19A2 gene-intron 1 mutation c.204+2T>G.
    Pomahačová R; Zamboryová J; Sýkora J; Paterová P; Fiklík K; Votava T; Černá Z; Jehlička P; Lád V; Šubrt I; Dort J; Dortová E
    Pediatr Diabetes; 2017 Dec; 18(8):844-847. PubMed ID: 28004468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Mutation of SLC19A2 in a Chinese Zhuang Ethnic Family with Thiamine-Responsive Megaloblastic Anemia.
    Xian X; Liao L; Shu W; Li H; Qin Y; Yan J; Luo J; Lin FQ
    Cell Physiol Biochem; 2018; 47(5):1989-1997. PubMed ID: 29969779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-Exome Sequencing Revealed a Pathogenic Nonsense Variant in the SLC19A2 Gene in an Iranian Family with Thiamine-Responsive Megaloblastic Anemia.
    Mohsen-Pour N; Naderi N; Ghasemi S; Hesami M; Maleki M; Kalayinia S
    Lab Med; 2022 Nov; 53(6):640-650. PubMed ID: 35686496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel nonsense mutation (p.Ile411Metfs*12) in the SLC19A2 gene causing Thiamine Responsive Megaloblastic Anemia in an Indian patient.
    Manimaran P; Subramanian VS; Karthi S; Gandhimathi K; Varalakshmi P; Ganesh R; Rathinavel A; Said HM; Ashokkumar B
    Clin Chim Acta; 2016 Jan; 452():44-9. PubMed ID: 26549656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation in the SLC19A2 gene in a Turkish male with thiamine-responsive megaloblastic anemia syndrome.
    Odaman-Al I; Gezdirici A; Yıldız M; Ersoy G; Aydoğan G; Şalcıoğlu Z; Tahtakesen TN; Önal H; Küçükemre-Aydın B
    Turk J Pediatr; 2019; 61(2):257-260. PubMed ID: 31951336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation in the SLC19A2 gene in a Turkish male with thiamine-responsive megaloblastic anemia syndrome.
    Odaman-Al I; Gezdirici A; Yıldız M; Ersoy G; Aydoğan G; Şalcıoğlu Z; Tahtakesen TN; Önal H; Küçükemre-Aydın B
    Turk J Pediatr; 2019; 61(2):257-260. PubMed ID: 31951337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiamine responsive megaloblastic anemia syndrome: a novel homozygous SLC19A2 gene mutation identified.
    Mikstiene V; Songailiene J; Byckova J; Rutkauskiene G; Jasinskiene E; Verkauskiene R; Lesinskas E; Utkus A
    Am J Med Genet A; 2015 Jul; 167(7):1605-9. PubMed ID: 25707023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mutation in the SLC19A2 gene in an Iranian family with thiamine-responsive megaloblastic anemia: a series of three cases.
    Ghaemi N; Ghahraman M; Abbaszadegan MR; Baradaran-Heravi A; Vakili R
    J Clin Res Pediatr Endocrinol; 2013 Sep; 5(3):199-201. PubMed ID: 24072090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infantile-onset thiamine responsive megaloblastic anemia syndrome with SLC19A2 mutation: a case report.
    Katipoğlu N; Karapinar TH; Demir K; Aydin Köker S; Nalbantoğlu Ö; Ay Y; Korkmaz HA; Oymak Y; Yıldız M; Tunç S; Hazan F; Vergin C; Ozkan B
    Arch Argent Pediatr; 2017 Jun; 115(3):e153-e156. PubMed ID: 28504500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report.
    Li X; Cheng Q; Ding Y; Li Q; Yao R; Wang J; Wang X
    BMC Pediatr; 2019 Jul; 19(1):233. PubMed ID: 31296181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter, SLC19A2.
    Enogieru OJ; Koleske ML; Vora B; Ngo H; Yee SW; Chatad D; Sirota M; Giacomini KM
    AAPS J; 2021 Mar; 23(2):35. PubMed ID: 33649974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiamine responsive megaloblastic anemia: a novel SLC19A2 compound heterozygous mutation in two siblings.
    Mozzillo E; Melis D; Falco M; Fattorusso V; Taurisano R; Flanagan SE; Ellard S; Franzese A
    Pediatr Diabetes; 2013 Aug; 14(5):384-7. PubMed ID: 23289844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leber's congenital amaurosis as the retinal degenerative phenotype in thiamine responsive megaloblastic anemia: a case report.
    Srikrupa NN; Meenakshi S; Arokiasamy T; Murali K; Soumittra N
    Ophthalmic Genet; 2014 Jun; 35(2):119-24. PubMed ID: 23638917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leber congenital amaurosis as an initial manifestation in a Chinese patient with thiamine-responsive megaloblastic anemia syndrome.
    Wu S; Yuan Z; Sun Z; Yao F; Sui R
    Am J Med Genet A; 2022 Mar; 188(3):948-952. PubMed ID: 34821467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiamine-responsive megaloblastic anemia (TRMA) in an Austrian boy with compound heterozygous SLC19A2 mutations.
    Pichler H; Zeitlhofer P; Dworzak MN; Diakos C; Haas OA; Kager L
    Eur J Pediatr; 2012 Nov; 171(11):1711-5. PubMed ID: 22576805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel compound heterozygous variants in SLC19A2 and the genotype-phenotype associations in thiamine-responsive megaloblastic anemia.
    Zhang S; Qiao Y; Wang Z; Zhuang J; Sun Y; Shang X; Li G
    Clin Chim Acta; 2021 May; 516():157-168. PubMed ID: 33571483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics in diabetes: outcomes of thiamine therapy in TRMA syndrome.
    Habeb AM; Flanagan SE; Zulali MA; Abdullah MA; Pomahačová R; Boyadzhiev V; Colindres LE; Godoy GV; Vasanthi T; Al Saif R; Setoodeh A; Haghighi A; Haghighi A; Shaalan Y; ; Hattersley AT; Ellard S; De Franco E
    Diabetologia; 2018 May; 61(5):1027-1036. PubMed ID: 29450569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a SLC19A2 nonsense mutation in Persian families with thiamine-responsive megaloblastic anemia.
    Setoodeh A; Haghighi A; Saleh-Gohari N; Ellard S; Haghighi A
    Gene; 2013 May; 519(2):295-7. PubMed ID: 23454484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss-of-Function Mutation in Thiamine Transporter 1 in a Family With Autosomal Dominant Diabetes.
    Jungtrakoon P; Shirakawa J; Buranasupkajorn P; Gupta MK; De Jesus DF; Pezzolesi MG; Panya A; Hastings T; Chanprasert C; Mendonca C; Kulkarni RN; Doria A
    Diabetes; 2019 May; 68(5):1084-1093. PubMed ID: 30833467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.